Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Lipid nanoparticle-enabled gene editing in the lung via inhalation

The ability to create in vivo genomic medicines for tissues other than the liver has been impeded by difficulties in delivery. Using a high-throughput platform, we developed lipid nanoparticles that can effectively deliver mRNA and CRISPR–Cas9 gene editing tools to the lungs through intratracheal administration, expanding the potential clinical uses of gene editing and mRNA-based technologies.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Fig. 1: LNP-enabled gene editing in mouse airway epithelium.


  1. Yin, H., Kauffman, K. J. & Anderson, D. G. Delivery technologies for genome editing. Nat. Rev. Drug Discov. 16, 387–399 (2017). This review article covers recent advances and challenges in nonviral and viral delivery methods.

    Article  CAS  PubMed  Google Scholar 

  2. Gillmore, J. D., Maitland, M. L. & Lebwohl, D. CRISPR–Cas9 in vivo gene editing for transthyretin amyloidosis. Reply. N. Engl. J. Med. 385, 1722–1723 (2021). This paper reports LNP-enabled CRISPR–Cas9 gene editing in a human trial.

    Article  PubMed  Google Scholar 

  3. Liang, S. Q. et al. AAV5 delivery of CRISPR–Cas9 supports effective genome editing in mouse lung airway. Mol. Ther. 30, 238–243 (2022). This paper reports using intratracheally dosed AAV for CRISPR–Cas9 gene editing in lung epithelium.

    Article  CAS  PubMed  Google Scholar 

  4. Patel, A. K. et al. Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium. Adv. Mater. 31, e1805116 (2019). This paper reports the use of inhaled mRNA nanopolyplexes for protein production in lung epithelium.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. (2023).

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lipid nanoparticle-enabled gene editing in the lung via inhalation. Nat Biotechnol (2023).

Download citation

  • Published:

  • DOI:


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research